Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
NCT07020546
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Infertility
- Poor Ovarian Reserve
- Embryo Growth Disorder
- in Vitro Fertilization
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 47 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Generation Next Fertility
- Last updated on ClinicalTrials.gov
- July 9, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Generation Next Fertility · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.